Ep. 107 - A Tale of Two Targets: LAG3, IL-2; Plus Alternatives to Cash Up
BioCentury This Week
00:00
Getting Bigger Deals in the New Year?
We've seen 30 public equity deals outside of traditional followons so far this year. And these deals have mostly been small. Do you expect to see bigger deals stealed, or should we continue to expect them to be fairly small? So the size of a deal is a function of the company's market cap. For a standard follow on, you do about maybe 20 % of what your market cap is.
Transcript
Play full episode
